Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 2.2B | 2.2B | 2.0B | 2.2B |
Cost of revenue | 905M | 876M | 771M | 927M |
Gross profit | 1.3B | 1.3B | 1.2B | 1.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 236M | 231M | 207M | 252M |
Other operating expenses | — | — | — | — |
Operating income | 1.0B | 996M | 978M | 956M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 397M | 378M | 378M | 343M |
Other income expense | -6M | 4M | 19M | -9M |
Pretax income | 635M | 622M | 619M | 605M |
Tax provision | 142M | 143M | 126M | 138M |
Net income | 493M | 479M | 493M | 467M |
Basic EPS | 8.5 | 8.2 | 7.6 | 5.8 |
Diluted EPS | 8.5 | 8.2 | 7.6 | 5.8 |
Basic average shares | 58.1M | 58.1M | 58.3M | 58M |
Diluted average shares | 58.1M | 58.1M | 58.3M | 58M |
EBITDA | 1.1B | 1.1B | 1.1B | 1.1B |
Net income from continuing op. | 493M | 479M | 493M | 467M |
Minority interests | -1M | 0 | 0 | 1M |
Preferred stock dividends | 0 | 0 | 49M | 132M |